-
Mashup Score: 0
Aims/hypothesis Weight reduction is fundamental for type 2 diabetes management and remission, but uncertainty exists over which diet type is best to achieve and maintain weight loss. We evaluated dietary approaches for weight loss, and remission, in people with type 2 diabetes to inform practice and clinical guidelines. Methods First, we conducted a systematic review of published meta-analyses of…
Source: DiabetologiaCategories: Cardiologists, Latest HeadlinesTweet
-
Mashup Score: 10
The American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD) convened a writing group to develop a consensus statement on the management of type 1 diabetes in adults. The writing group has considered the rapid development of new treatments and technologies and addressed the following topics: diagnosis, aims of management, schedule of care, diabetes…
Source: DiabetologiaCategories: Cardiologists, Latest HeadlinesTweet-
A consensus report by the #ADA ) and #EASD in Type1 #Diabetes https://t.co/OnLjptnbAN
-
-
Mashup Score: 5
Diabetologia –
Source: DiabetologiaCategories: Healthcare Professionals, Latest HeadlinesTweet-
On the causal relationships between hyperinsulinaemia, insulin resistance, #obesity and dysglycaemia in type 2 diabetes: Reply to Johnson JD [letter] | SpringerLink #weight #weightgain #weightloss https://t.co/o5ube52uiL
-
-
Mashup Score: 7Effects of the SGLT2 inhibitor canagliflozin on plasma biomarkers TNFR-1, TNFR-2 and KIM-1 in the CANVAS trial - Diabetologia - 3 year(s) ago
Aims/hypothesis Higher plasma concentrations of tumour necrosis factor receptor (TNFR)-1, TNFR-2 and kidney injury molecule-1 (KIM-1) have been found to be associated with higher risk of kidney failure in individuals with type 2 diabetes in previous studies. Whether drugs can reduce these biomarkers is not well established. We measured these biomarkers in samples of the CANVAS study and examined…
Source: DiabetologiaCategories: Healthcare Professionals, Latest HeadlinesTweet-
In people with diabetes, SGLT2 inhibition attenuated increases in TNFR-1&2 and decreased KIM-1 over time, which are markers of inflammation and fibrosis Our biomarker study from CANVAS with @KidneydrChirag & @scoca1 published in @DiabetologiaJnl https://t.co/Bs7nVetzl5 https://t.co/EapnAidFlN
-
-
Mashup Score: 4
Aims/hypothesis We aimed to investigate the associations between maternal diabetes before or during pregnancy and the risk of high refractive error (RE) in offspring until the age of 25 years. Methods This nationwide register-based cohort study comprised 2,470,580 individuals born in 1977–2016. The exposure was maternal diabetes during or before pregnancy (type 1 diabetes, type 2 diabetes and…
Source: DiabetologiaCategories: Healthcare Professionals, Latest HeadlinesTweet-
A new study finds that mothers who have #diabetes before or during their #pregnancy are more likely to have children who go on to develop #eye problems. https://t.co/V6Acaqx3Fq https://t.co/nHyyF9RplY
-
-
Mashup Score: 7Youth-onset type 2 diabetes: translating epidemiology into clinical trials - Diabetologia - 3 year(s) ago
Globally, the proportion of new diagnoses of youth-onset diabetes represented by type 2 diabetes is increasing, and youth with type 2 diabetes commonly have complications and comorbidities, as well as a higher rate of mortality. In this review, we summarise what is known about the natural progression of youth-onset type 2 diabetes from published clinical trials and large-scale prospective…
Source: DiabetologiaCategories: Cardiologists, Latest HeadlinesTweet-
Youth-onset type 2 #diabetes : translating epidemiology into clinical trials. More important is the political decisions to promote healthy lifestyle at school and in families. Main is linked to #obesity and physical #inactivity https://t.co/cMWMJhUx0y
-
Youth-onset type 2 #diabetes : translating epidemiology into clinical trials. More important is the political decisions to promote healthy lifestyle at school and in families. Main is linked to #obesity and physical #inactivity https://t.co/cMWMJhUx0y
-
-
Mashup Score: 1Major adverse cardiovascular and limb events in patients with diabetes treated with GLP-1 receptor agonists vs DPP-4 inhibitors - Diabetologia - 3 year(s) ago
Aims/hypothesis The safety and efficacy of glucagon-like peptide-1 receptor agonists (GLP1RAs) and dipeptidyl peptidase-4 inhibitors (DPP4is) in major cardiovascular adverse events were previously examined in cardiovascular outcome trials. However, the effects of these drugs on adverse limb outcomes were poorly examined. This study aimed to determine the real-world outcomes of patients with…
Source: DiabetologiaCategories: Cardiologists, Latest HeadlinesTweet-
Major adverse CV and limb events in patients with #DM treated with GLP-1 receptor agonists vs DPP-4 inhibitors #GLP1RAs was associated with significantly ⬇️ risks of major adverse limb events when compared with the use of DPP4is https://t.co/FJipfEGwHJ @DrDave01 @DLBHATTMD https://t.co/eOVXFzelCy
-
-
Mashup Score: 1Are people with metabolically healthy obesity really healthy? A prospective cohort study of 381,363 UK Biobank participants - 3 year(s) ago
Aims/hypothesis People with obesity and a normal metabolic profile are sometimes referred to as having ‘metabolically healthy obesity’ (MHO). However, whether this group of individuals are actually ‘healthy’ is uncertain. This study aims to examine the associations of MHO with a wide range of obesity-related outcomes. Methods This is a population-based prospective cohort study of 381,363 UK…
Source: DiabetologiaCategories: Healthcare Professionals, Latest HeadlinesTweet-
Are people with metabolically healthy #obesity really healthy? A prospective cohort study of 381,363 UK Biobank participants | SpringerLink https://t.co/vJmlrL0TWo
-
-
Mashup Score: 4Are people with metabolically healthy obesity really healthy? A prospective cohort study of 381,363 UK Biobank participants - 3 year(s) ago
Aims/hypothesis People with obesity and a normal metabolic profile are sometimes referred to as having ‘metabolically healthy obesity’ (MHO). However, whether this group of individuals are actually ‘healthy’ is uncertain. This study aims to examine the associations of MHO with a wide range of obesity-related outcomes. Methods This is a population-based prospective cohort study of 381,363 UK…
Source: DiabetologiaCategories: Cardiologists, Latest HeadlinesTweet-
Fat but Fit. ‘metabolically healthy obesity’ is a myth! Obese individuals(BMI ≥ 30 kg/m2)who regularly exercise are at an increased risk of heart disease, T2 diabetes and respiratory diseases irrespective of their metabolic profile. https://t.co/5eOPrQBXtF #weightloss https://t.co/bdglJvnMUu
-
-
Mashup Score: 19Are people with metabolically healthy obesity really healthy? A prospective cohort study of 381,363 UK Biobank participants - 3 year(s) ago
Aims/hypothesis People with obesity and a normal metabolic profile are sometimes referred to as having ‘metabolically healthy obesity’ (MHO). However, whether this group of individuals are actually ‘healthy’ is uncertain. This study aims to examine the associations of MHO with a wide range of obesity-related outcomes. Methods This is a population-based prospective cohort study of 381,363 UK…
Source: DiabetologiaCategories: Healthcare Professionals, Latest HeadlinesTweet-
RT @DanielJDrucker: Should we abandon the diagnosis of metabolically healthy #obesity @DiabetologiaJnl https://t.co/cv3bGS4IBe
-
"Published meta-analyses of hypocaloric diets for weight management in people with type 2 diabetes do not support any particular macronutrient profile or style over others" https://t.co/8rDKziOfLa https://t.co/Bc3ze9y1yf